Therapeutic targeting of regulatory T cells in cancer

F Shan, A Somasundaram, TC Bruno, CJ Workman… - Trends in cancer, 2022 - cell.com
The success of immunotherapy in oncology underscores the vital role of the immune system
in cancer development. Regulatory T cells (Tregs) maintain a fine balance between …

Immune parameters affecting the efficacy of chemotherapeutic regimens

L Zitvogel, O Kepp, G Kroemer - Nature reviews Clinical oncology, 2011 - nature.com
The outcome of chemotherapy can be influenced by the host immune system at multiple
levels. Chemotherapy can kill cancer cells by causing them to elicit an immune response or …

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer

C Denkert, S Loibl, A Noske, M Roller… - Journal of clinical …, 2010 - ascopubs.org
Purpose Preclinical data suggest a contribution of the immune system to chemotherapy
response. In this study, we investigated the prespecified hypothesis that the presence of a …

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical …

M Gobert, I Treilleux, N Bendriss-Vermare, T Bachelot… - Cancer research, 2009 - AACR
Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high
number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates …

[HTML][HTML] Metabolic crosstalk in the breast cancer microenvironment

AS Dias, CR Almeida, LA Helguero, IF Duarte - European Journal of …, 2019 - Elsevier
During tumorigenesis, breast tumour cells undergo metabolic reprogramming, which
generally includes enhanced glycolysis, tricarboxylic acid cycle activity, glutaminolysis and …

[HTML][HTML] CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome

Y Huang, C Ma, Q Zhang, J Ye, F Wang, Y Zhang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract The Cancer Immunoediting concept has provided critical insights suggesting dual
functions of immune system during the cancer initiation and development. However, the …

What are regulatory T cells (Treg) regulating in cancer and why?

TL Whiteside - Seminars in cancer biology, 2012 - Elsevier
The role regulatory T cells (Treg) play in cancer development and progression is not clear.
Earlier evidence suggested that CD4+ FOXP3+ CD25high Treg accumulate in tumors and …

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T …

S Ladoire, L Arnould, L Apetoh, B Coudert, F Martin… - Clinical cancer …, 2008 - AACR
Purpose: T-cell infiltration is associated with good tumor prognosis in many cancers. To
assess the capacity of neoadjuvant chemotherapy to affect T-cell infiltration in breast cancer …

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer

C Ma, Q Zhang, J Ye, F Wang, Y Zhang… - The Journal of …, 2012 - journals.aai.org
Understanding and dissecting the role of different subsets of regulatory tumor-infiltrating
lymphocytes (TILs) in the immunopathogenesis of individual cancer is a challenge for anti …

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

S Ladoire, G Mignot, S Dabakuyo… - The Journal of …, 2011 - Wiley Online Library
Accumulating preclinical evidence suggests that anticancer immune responses contribute to
the success of chemotherapy. However, the predictive value of tumour‐infiltrating …